Abstract: Diabetic retinopathy (DR) remains one of the most common non-communicable diseases globally and poses a major public health challenge due to its increasing prevalence, associated complications, and economic burden. Despite advances in diagnostic technology and management, disparities in screening uptake persist, particularly in low- and middle-income countries where awareness, knowledge and healthcare accessibility are limited.